Subcutaneous apomorphine for neuroleptic malignant syndrome

Am J Psychiatry. 2006 Aug;163(8):1450-1. doi: 10.1176/ajp.2006.163.8.1450.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Apomorphine / administration & dosage*
  • Apomorphine / therapeutic use
  • Dopamine Agonists / administration & dosage*
  • Dopamine Agonists / therapeutic use
  • Drug Administration Schedule
  • Female
  • Humans
  • Injections, Subcutaneous
  • Middle Aged
  • Neuroleptic Malignant Syndrome / drug therapy*
  • Treatment Outcome

Substances

  • Dopamine Agonists
  • Apomorphine